The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: A systematic review protocol

Salma M. Khaled, Elizabeth Hughes, Dan Bressington, Monica Zolezzi, Ahmed Radwan, Ashish Badnapurkar, Richard Gray

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Novel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not controlled by the United Nations drug convention that may pose a serious public health threat due to their wide availability for purchase on the internet and in so called "head shops." Yet, the extent of their global use remains largely unknown. The aim of this study is to conduct a systematic review of the prevalence of NPS use in non-clinical populations. Methods: This is a systematic review of observational studies. Embase, MEDLINE, PubMed, Cumulative Index to Nursing and Allied Health (CINAHL), Cochrane Library, Lilacs, Scopus, Global Health, PsychINFO, Web of Science, and the World Health Organization (WHO) regional databases will be searched for eligible prevalence studies published between 2010 and 2016. Data from cross-sectional studies that report the prevalence of NPS use (one or more types) in participants (of any age) from censuses or probabilistic or convenience samples will be included. Data will be extracted from eligible publications, using a data extraction tool developed for this study. Visual and statistical approaches will be adopted instead of traditional meta-analytic approaches. Discussion: This review will describe the distributions of various types of prevalence estimates of NPS use and explore the impact of different population groups and study-related and tempo-geographical variables on characteristics of these distributions over the period of 2010 to 2016. Systematic review registration: PROSPERO CRD42016037020

LanguageEnglish
Article number195
JournalSystematic Reviews
Volume5
Issue number1
DOIs
Publication statusPublished - 21 Nov 2016

Fingerprint

Cross-Sectional Studies
Population
United Nations
Psychotropic Drugs
Narcotics
Censuses
Population Groups
PubMed
MEDLINE
Internet
Libraries
Observational Studies
Publications
Nursing
Public Health
Head
Databases
Health
Pharmaceutical Preparations
Global Health

Cite this

Khaled, S. M., Hughes, E., Bressington, D., Zolezzi, M., Radwan, A., Badnapurkar, A., & Gray, R. (2016). The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: A systematic review protocol. Systematic Reviews, 5(1), [195]. https://doi.org/10.1186/s13643-016-0375-5
Khaled, Salma M. ; Hughes, Elizabeth ; Bressington, Dan ; Zolezzi, Monica ; Radwan, Ahmed ; Badnapurkar, Ashish ; Gray, Richard. / The prevalence of novel psychoactive substances (NPS) use in non-clinical populations : A systematic review protocol. In: Systematic Reviews. 2016 ; Vol. 5, No. 1.
@article{9997e395acc340bca44882819bb46f2c,
title = "The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: A systematic review protocol",
abstract = "Background: Novel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not controlled by the United Nations drug convention that may pose a serious public health threat due to their wide availability for purchase on the internet and in so called {"}head shops.{"} Yet, the extent of their global use remains largely unknown. The aim of this study is to conduct a systematic review of the prevalence of NPS use in non-clinical populations. Methods: This is a systematic review of observational studies. Embase, MEDLINE, PubMed, Cumulative Index to Nursing and Allied Health (CINAHL), Cochrane Library, Lilacs, Scopus, Global Health, PsychINFO, Web of Science, and the World Health Organization (WHO) regional databases will be searched for eligible prevalence studies published between 2010 and 2016. Data from cross-sectional studies that report the prevalence of NPS use (one or more types) in participants (of any age) from censuses or probabilistic or convenience samples will be included. Data will be extracted from eligible publications, using a data extraction tool developed for this study. Visual and statistical approaches will be adopted instead of traditional meta-analytic approaches. Discussion: This review will describe the distributions of various types of prevalence estimates of NPS use and explore the impact of different population groups and study-related and tempo-geographical variables on characteristics of these distributions over the period of 2010 to 2016. Systematic review registration: PROSPERO CRD42016037020",
keywords = "Club drugs, Designer drugs, Epidemiology, Internet drugs, Legal highs, New psychoactive substances, Novel psychoactive substances, Prevalence, Psychiatric morbidity, Research chemicals",
author = "Khaled, {Salma M.} and Elizabeth Hughes and Dan Bressington and Monica Zolezzi and Ahmed Radwan and Ashish Badnapurkar and Richard Gray",
year = "2016",
month = "11",
day = "21",
doi = "10.1186/s13643-016-0375-5",
language = "English",
volume = "5",
journal = "Systematic Reviews",
issn = "2046-4053",
publisher = "BioMed Central",
number = "1",

}

Khaled, SM, Hughes, E, Bressington, D, Zolezzi, M, Radwan, A, Badnapurkar, A & Gray, R 2016, 'The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: A systematic review protocol', Systematic Reviews, vol. 5, no. 1, 195. https://doi.org/10.1186/s13643-016-0375-5

The prevalence of novel psychoactive substances (NPS) use in non-clinical populations : A systematic review protocol. / Khaled, Salma M.; Hughes, Elizabeth; Bressington, Dan; Zolezzi, Monica; Radwan, Ahmed; Badnapurkar, Ashish; Gray, Richard.

In: Systematic Reviews, Vol. 5, No. 1, 195, 21.11.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The prevalence of novel psychoactive substances (NPS) use in non-clinical populations

T2 - Systematic Reviews

AU - Khaled, Salma M.

AU - Hughes, Elizabeth

AU - Bressington, Dan

AU - Zolezzi, Monica

AU - Radwan, Ahmed

AU - Badnapurkar, Ashish

AU - Gray, Richard

PY - 2016/11/21

Y1 - 2016/11/21

N2 - Background: Novel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not controlled by the United Nations drug convention that may pose a serious public health threat due to their wide availability for purchase on the internet and in so called "head shops." Yet, the extent of their global use remains largely unknown. The aim of this study is to conduct a systematic review of the prevalence of NPS use in non-clinical populations. Methods: This is a systematic review of observational studies. Embase, MEDLINE, PubMed, Cumulative Index to Nursing and Allied Health (CINAHL), Cochrane Library, Lilacs, Scopus, Global Health, PsychINFO, Web of Science, and the World Health Organization (WHO) regional databases will be searched for eligible prevalence studies published between 2010 and 2016. Data from cross-sectional studies that report the prevalence of NPS use (one or more types) in participants (of any age) from censuses or probabilistic or convenience samples will be included. Data will be extracted from eligible publications, using a data extraction tool developed for this study. Visual and statistical approaches will be adopted instead of traditional meta-analytic approaches. Discussion: This review will describe the distributions of various types of prevalence estimates of NPS use and explore the impact of different population groups and study-related and tempo-geographical variables on characteristics of these distributions over the period of 2010 to 2016. Systematic review registration: PROSPERO CRD42016037020

AB - Background: Novel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not controlled by the United Nations drug convention that may pose a serious public health threat due to their wide availability for purchase on the internet and in so called "head shops." Yet, the extent of their global use remains largely unknown. The aim of this study is to conduct a systematic review of the prevalence of NPS use in non-clinical populations. Methods: This is a systematic review of observational studies. Embase, MEDLINE, PubMed, Cumulative Index to Nursing and Allied Health (CINAHL), Cochrane Library, Lilacs, Scopus, Global Health, PsychINFO, Web of Science, and the World Health Organization (WHO) regional databases will be searched for eligible prevalence studies published between 2010 and 2016. Data from cross-sectional studies that report the prevalence of NPS use (one or more types) in participants (of any age) from censuses or probabilistic or convenience samples will be included. Data will be extracted from eligible publications, using a data extraction tool developed for this study. Visual and statistical approaches will be adopted instead of traditional meta-analytic approaches. Discussion: This review will describe the distributions of various types of prevalence estimates of NPS use and explore the impact of different population groups and study-related and tempo-geographical variables on characteristics of these distributions over the period of 2010 to 2016. Systematic review registration: PROSPERO CRD42016037020

KW - Club drugs

KW - Designer drugs

KW - Epidemiology

KW - Internet drugs

KW - Legal highs

KW - New psychoactive substances

KW - Novel psychoactive substances

KW - Prevalence

KW - Psychiatric morbidity

KW - Research chemicals

UR - http://www.scopus.com/inward/record.url?scp=84998880952&partnerID=8YFLogxK

U2 - 10.1186/s13643-016-0375-5

DO - 10.1186/s13643-016-0375-5

M3 - Article

VL - 5

JO - Systematic Reviews

JF - Systematic Reviews

SN - 2046-4053

IS - 1

M1 - 195

ER -